Preventive Care
Conference Coverage
Dubious diagnosis: Is there a better way to define ‘prediabetes’?
There have been major increases in prediabetes in the United States and globally over the past 2 decades.
Latest News
Can a common artificial sweetener fuel anxiety?
Mice that drank water containing aspartame exhibited pronounced anxiety-like behaviors in a variety of maze tests.
From the Journals
Scientists use mRNA technology for universal flu vaccine
Two years ago marked a significant moment for messenger RNA (mRNA) technology.
Feature
COVID booster shot poll: People ‘don’t think they need one’
A new poll shows why so few people are willing to get the latest COVID booster.
From the Journals
AI versus other interventions for colonoscopy: How do they compare?
“Numerous interventions have been attempted and researched to see the impact on ADR ... I knew that AI was impactful in improving ADR, but I didn’...
From the Journals
The 'Plaque Hypothesis': Focus on vulnerable lesions to cut events
A new strategy is needed that targets unstable plaque in the whole of the coronary arteries, rather than just obstructive lesions, to reduce major...
Feature
Multiple myeloma diagnosed more via emergency care during COVID
While trying to avoid COVID-19 infection, patients ultimately diagnosed with multiple myeloma may have delayed interactions with healthcare...
Feature
Bite-sized bouts of exercise: Why they are valuable and what they are missing
Short, intense bursts of physical activity offer entry into exercise for less active individuals.
From the Journals
Fitbit figures: More steps per day cut type 2 diabetes risk
The protective effect of daily step count on type 2 diabetes risk remained after adjusting for smoking and sedentary time.
Latest News
AI takes root in primary care. First stop: Diabetic retinopathy
This technology “can potentially help us in decreasing disparities in care and focusing our efforts on patients with the most severe diseases.”
From the Journals
New test that detects 14 cancers focuses on sugars, not DNA
“The main advantage of glycosaminoglycans appears to be that they change in the blood and urine at the earliest stages of cancer.”